tiprankstipranks
Respiri Limited (RSHUF)
OTHER OTC:RSHUF

Respiri Limited (RSHUF) Stock Price & Analysis

4 Followers

RSHUF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range<$0.01 - $0.06
Previous Close$0.01
Volume105.00K
Average Volume (3M)N/A
Market Cap
$20.76M
Enterprise Value$20.01M
Total Cash (Recent Filing)AU$1.22M
Total Debt (Recent Filing)AU$70.66K
Price to Earnings (P/E)-2.0
Beta0.23
Aug 28, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,059,868,924
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.54
R-Squared0.00047
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

23.97%0.00%0.00%76.03%
23.97% Insiders
0.00% Other Institutional Investors
76.03% Public Companies and
Individual Investors

RSHUF FAQ

What was Respiri Limited’s price range in the past 12 months?
Respiri Limited lowest stock price was <$0.01 and its highest was $0.06 in the past 12 months.
    What is Respiri Limited’s market cap?
    Currently, no data Available
    When is Respiri Limited’s upcoming earnings report date?
    Respiri Limited’s upcoming earnings report date is Aug 28, 2024 which is in 132 days.
      How were Respiri Limited’s earnings last quarter?
      Respiri Limited released its earnings results on Feb 29, 2024. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
        Is Respiri Limited overvalued?
        According to Wall Street analysts Respiri Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Respiri Limited pay dividends?
          Respiri Limited does not currently pay dividends.
          What is Respiri Limited’s EPS estimate?
          Respiri Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Respiri Limited have?
          Respiri Limited has 1,059,868,900 shares outstanding.
            What happened to Respiri Limited’s price movement after its last earnings report?
            Respiri Limited reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Respiri Limited?
              Currently, no hedge funds are holding shares in RSHUF
              ---

              Respiri Limited Stock Smart Score

              Company Description

              Respiri Limited

              Respiri Ltd. engages in research, development, and commercialization of medical devices and the production of mobile health applications for management of asthma and related chronic respiratory diseases. Its proprietary apps, software, and devices will help people monitor the symptoms of their conditions, increase their awareness of risk of attack, adhere to their medication plans, improve outcomes, and reduce healthcare expenditures. It operates through the Australia and Israel segments. The Australia segment includes research, development, and commercialization of medical devices, and the production of mobile health applications in Australia. The Israel segment refers to the research, development and, commercialization of medical devices, and the production of mobile health applications in Israel. The company was founded by Noam Gavriely in 1987 and is headquartered in Melbourne, Australia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Avinger
              CytoDyn
              Exact Sciences
              Alcon
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis